胰岛素帮浦·持续血糖监测仪的全球市场 - 市场规模(各市场区隔)，占有率，法规，偿付，运作台数，预测(～2033年)

本报告提供全球胰岛素帮浦·持续血糖监测仪市场相关调查分析，提供主要企业市场占有率，主要趋势，创新的产品与技术，竞争情形等资讯。

市场模式的主要内容如下列。

已上市的胰岛素帮浦·持续血糖监测仪与不断变化的竞争格局

• 主要的产业趋势的考察
• 胰岛素帮浦·持续血糖监测仪市场区隔的年度收益与市场预测(2015年～2033年)
• 有关各市场区隔的整体治疗数，台数，平均销售价格，市场金额的详细的资料

世界，地区，国家层级的市场固有的考察

• 各地区分类的全球趋势之特定市场定性资讯和国家/地区考虑因素
• 胰岛素帮浦·持续血糖监测仪市场SWOT分析
• 胰岛素帮浦·持续血糖监测仪市场竞争动态的考察和趋势

透过对医疗保健系统的真实、全面的了解来促进市场理解。市场进入部分还提供有关报销政策和监管环境的信息，使您能够更深入地研究市场动态。

• 各国医疗制度概要
• 各国偿付政策
• 各国医疗技术相关法规形势

对象企业

• Medtronic Plc
• Abbott Laboratories
• DexCom Inc
• Senseonics Holdings Inc
• Insulet Corp
• F. Hoffmann-La Roche Ltd
• Ypsomed Holding AG
• Tandem Diabetes Care Inc
• MannKind Corp
• 其他

Insulin Pumps and Continuous Glucose Monitors Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Patient Monitoring therapeutic area.

An insulin pump is an insulin delivery device that administers programmed doses of insulin for diabetes management. An Insulin Pump consists of a battery run pump, an insulin reservoir and an infusion set with a tubing system for subcutaneous intervention.

Glucose monitoring devices are used for time defined or continuous measurement of blood glucose. Glucose monitoring does not include devices for ketone body testing or of any other blood constituents other than glucose. Blood glucose meters are tracked under this category.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Insuline Pumps and Continuous Glucose Monitors and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Insuline Pumps and Continuous Glucose Monitors market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Insuline Pumps and Continuous Glucose Monitors market.
• Competitive dynamics insights and trends provided Insuline Pumps and Continuous Glucose Monitors market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic Plc, Abbott Laboratories, DexCom Inc, Senseonics Holdings Inc, Insulet Corp, F. Hoffmann-La Roche Ltd, Ypsomed Holding AG, Tandem Diabetes Care Inc, MannKind Corp, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Insuline Pumps and Continuous Glucose Monitors marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Insuline Pumps and Continuous Glucose Monitors market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Insuline Pumps and Continuous Glucose Monitors market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Insuline Pumps and Continuous Glucose Monitors market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.